Literature DB >> 1447663

3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects.

K M Gibson1, M J Bennett, C E Mize, C Jakobs, A Rotig, A Munnich, U Lichter-Konecki, F K Trefz.   

Abstract

3-Methylglutaconic aciduria was detected in four patients with Pearson syndrome, a multitissue disorder with hematologic abnormalities, lactic acidosis resulting from defective oxidative phosphorylation, and deletions in the mitochondrial genome. 3-Methylglutaconic acid may be an additional useful marker for Pearson syndrome and may be a more specific marker than other organic acids identified in this disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447663     DOI: 10.1016/s0022-3476(05)80348-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  3-Methylglutaconic aciduria and hypermethioninaemia in a child with clinical and neuroradiological findings of Leigh disease.

Authors:  M Di Rocco; U Caruso; I Moroni; S Lupino; E Lamantea; A R Fantasia; C Borrone; K M Gibson
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Mutation characterization and genotype-phenotype correlation in Barth syndrome.

Authors:  J Johnston; R I Kelley; A Feigenbaum; G F Cox; G S Iyer; V L Funanage; R Proujansky
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

3.  Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews.

Authors:  Y Anikster; R Kleta; A Shaag; W A Gahl; O Elpeleg
Journal:  Am J Hum Genet       Date:  2001-10-19       Impact factor: 11.025

Review 4.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060).

Authors:  P G Barth; R J Wanders; P Vreken; E A Janssen; J Lam; F Baas
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

5.  3-Methylglutaconic aciduria--lessons from 50 genes and 977 patients.

Authors:  Saskia B Wortmann; Leo A J Kluijtmans; Richard J Rodenburg; Jörn Oliver Sass; Jessica Nouws; Edwin P van Kaauwen; Tjitske Kleefstra; Lisbeth Tranebjaerg; Maaike C de Vries; Pirjo Isohanni; Katharina Walter; Fowzan S Alkuraya; Izelle Smuts; Carolus J Reinecke; Francois H van der Westhuizen; David Thorburn; Jan A M Smeitink; Eva Morava; Ron A Wevers
Journal:  J Inherit Metab Dis       Date:  2013-01-25       Impact factor: 4.982

6.  Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica).

Authors:  Piero Farruggia; Andrea Di Cataldo; Rita M Pinto; Elena Palmisani; Alessandra Macaluso; Laura Lo Valvo; Maria E Cantarini; Assunta Tornesello; Paola Corti; Francesca Fioredda; Stefania Varotto; Baldo Martire; Isabella Moroni; Giuseppe Puccio; Giovanna Russo; Carlo Dufour; Marta Pillon
Journal:  JIMD Rep       Date:  2015-08-04

7.  Mitochondrial disease in superoxide dismutase 2 mutant mice.

Authors:  S Melov; P Coskun; M Patel; R Tuinstra; B Cottrell; A S Jun; T H Zastawny; M Dizdaroglu; S I Goodman; T T Huang; H Miziorko; C J Epstein; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

Review 8.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 9.  Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review.

Authors:  Takeshi Sato; Koji Muroya; Junko Hanakawa; Reiko Iwano; Yumi Asakura; Yukichi Tanaka; Kei Murayama; Akira Ohtake; Tomonobu Hasegawa; Masanori Adachi
Journal:  Eur J Pediatr       Date:  2015-06-16       Impact factor: 3.183

Review 10.  The 3-methylglutaconic acidurias: what's new?

Authors:  Saskia B Wortmann; Leo A Kluijtmans; Udo F H Engelke; Ron A Wevers; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.